The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria

AIDS Research and Therapy

Volumn 7, Issue , 2010, Pages

  Taiwo, Olaniyi O ^a   Hassan, Zuwaira ^b  

^a Regional Centre for Oral Health Research and Training Initiatives RCORTI for Africa   (Nigeria)

^b UNIVERSITY OF JOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; NEVIRAPINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAMERA; CHEILITIS; CLINICAL FEATURE; CONTROLLED STUDY; DIGITAL IMAGING; DISEASE ASSOCIATION; ERYTHEMA; FEMALE; GINGIVA DISEASE; HAIRY LEUKOPLAKIA; HERPES SIMPLEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERPIGMENTATION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MOUTH LESION; MOUTH ULCER; NIGERIA; PAROTID ENLARGEMENT; PHOTOGRAPHY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; THRUSH; XEROSTOMIA;

EID: 77954569604     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-7-19     Document Type: Article

References (17)

1. Schmidt-Westhausen AM, Priepke F, Bergman FJ, Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active retroviral therapy. J Oral Pathol Med 2000, 29:336-41. 10.1034/j.1600-0714.2000.290708.x, 10947250.
2. Ramirez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, Gonzalez-Ramirez I, Ponce-de-Leon S. The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1,000 consecutive patients: a 12 year study in a referral centre in Mexico. Medicine 2003, 82:39-50. 10.1097/00005792-200301000-00004, 12544709.
3. Greenspan JS, Greenspan D. The epidemiology of the Oral lesions of HIV infection in the developed world. Oral Dis 2002, 8:34-39. 10.1034/j.1601-0825.2002.00009.x, 12164657.
4. Bascones A, Serrano C, Campo J. Oral manifestations of HIV infection. Med Clin (Barc) 2003, 120:426-34. 10.1157/13045299, 12681223.
5. Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effects of Highly Active Antiretroviral Therapy on Frequency of Oral Warts. Lancet 2001, 357:1411-2. 10.1016/S0140-6736(00)04578-5, 11356441.
6. Bendick C, Schelfele C, Reichart PA. Oral manifestations in 101 Cambodian patients with HIV infection and AIDS. J Oral Pathol Med 2002, 31:1-4. 10.1034/j.1600-0714.2002.310101.x, 11896815.
7. Eyeson JD, Tenant-Flowers M, Cooper DJ, Johnson NW, Warnakulasuriya KA. Oral manifestations of an HIV positive cohort in the era of highly active antiretroviral therapy (HAART) in South London. J. Oral Pathol Med 2002, 31:169-74. 10.1034/j.1600-0714.2002.310308.x, 11903824.
8. Tappuni AR, Fleming GJ. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 92:623-8. 10.1067/moe.2001.118902, 11740479.
9. Wiebe CB, Epstein JB. An Atlas of HIV-Associated Oral lesions: A New Classification and Diagnostic Criteria. J Can Dent Assoc 1997, 63:288-9. 292-4.
10. Birnbaum W, Hodgson TA, Reichart PA, Sherson W, Nittayannanta SW, Axell TE. Prognostic significance of HIV-associated oral lesions and their relation to therapy. Oral Dis 2002, 8:110-4. 10.1034/j.1601-0825.2002.00021.x, 12164643.
11. Ikumi G, Akira Y, Kiyoshi S, Shinichi O. Highly active antiretroviral therapy for the treatment of Kaposi's Sarcoma associated with primary human immunodeficiency virus type -1 infection. Jpn. J. Infect. Dis 2000, 166-67.
12. Gaitan-Cepeda LA, Ceballos-Salobrena A, Martinez-Gonzalez. Oral candidosis as clinical marker of immune failure in patients with HIV/AIDS on HAART. AIDS Patient Care and STDS 2005, 19:70-77. 10.1089/apc.2005.19.70, 15716638.
13. Aquino-Garcia SI, Rivas MA, Ceballos-Salobrena A, Acosta-Gio AE, Gaitan-Cepeda LA. Oral lesions in HIV/AIDS patients undergoing HAART including Efavirenz. AIDS Res Hum Retroviruses 2008, 24:815-820. 10.1089/aid.2007.0159, 18507528.
14. Ortega KL, Ceballos-Salobrena A, Gaitan-Cepeda LA, Magalhaes MG. Oral manifestations after immune reconstitution in HIV patients on HAART. International Journal of STD & AIDS 2008, 19:305-308.
15. Nittayanata W. Oral manifestations in adults with HIV/AIDS. Oral manifestations of HIV infection (current update with Asian focus) 2004, 25-52. Printing House, Nittayanata W, Bangkok OS.
16. Hamza OIM, Matee MIN, Simon ENM, Kikwilu E, Moshi MJ, Mugusi F, et al. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy (HAART) in Dar es Salaam, Tanzania. BMC Oral Health 2006, 6:12. 10.1186/1472-6831-6-12, 1559688, 16916469.
17. Nicolatou-Galitis O, Velegraki A, Paikos S, Economopoulou P, Stefaniotis T, Papanikoloau IS, et al. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study. Oral Dis 2004, 10:145-50. 10.1046/j.1601-0825.2003.00994.x, 15089923.